Linde-KCA-Dresden GmbH Germany
Linde Group
Search
Sitemap Contact Deutsch
Linde-KCA-Dresden GmbHGermany
Home Biotechnological Plants Plants for the Pharmaceutical Biotechnology

Plants for the Pharmaceutical Biotechnology

The production of active pharmaceutical ingredients using biotechnological processes, including genetic engineering, is a young, dynamically developing branch of the industry.

The biotechnological process steps of synthesis (fermentation), processing and high-purification (down-stream processing) of active substances differ considerably from the chemical syntheses. The technological solutions are as innovative and new as the branch of industry is. With the Biotechnology, a completely new area of dimensioning in process engineering and plant design has been generated now shaping a whole generation of engineers.

As from the beginning of the growing importance of the industrial scale application of biotechnology in the European pharma industry, Linde-KCA-Dresden has played a pioneer role. The biotechnology demands an extremely close connection of product and plant development. Linde-KCA-Dresden was prepared to cope with this trend. That way, Linde-KCA-Dresden cooperated in the process development for the production of Hepatitis-B-Vaccine and developed a specific "Front-End Engineering" approach (PDF, 269,5Kb), that constitutes an efficient approach to minimize the risk of biotechnology projects.

Our engineers have gained experience in planning of biotechnological plants, in particular gene technological plants that are characterized by the key criterion sterility beginning from processes based on yeast and bacteria up to processes on the basis of animal cell cultures modified by genetic engineering.





Selected references

Example 1
Cell culture plant for production of MAB

Basle

Client

F. Hoffmann-La Roche AG

Location

Basle / Switzerland

Type of plant

New cell culture plant for production of monoclonal antibodies (MAB)

Product

Anticancer drug Avastin

Scope of work

List Bullet Project coordination
List Bullet Concept design, basic design, detail design
List Bullet Support in procurement
List Bullet Engineering support during installation and commissioning

Commissioning

2007



Example 2
Revamp of an Insulin plant


Kalundborg

Client

Novo Nordisk A / S

Location

Kalundborg / Denmark

Type of plant

Plant for the final Purification of an Insulin Analogue (PIA)

Product

Recombinant insulin analogue

Production process

Insulin purification

Scope of work

List Bullet Detail engineering
List Bullet Procurement
List Bullet Construction management
List Bullet Commissioning
List Bullet Qualification

Planning period

2006 / 2007



Example 3
Biotechnological plant for the production of EPO


Penzberg

Client

Roche Diagnostics GmbH

Location

Penzberg/ Germany

Type of plant

New cell culture plant on a scale of 5.000 l

Product

EPO (Erythropoietin)

Scope of work

List Bullet Concept design
List Bullet Basic design
List Bullet Detail design
List Bullet Support in procurement
List Bullet Design support during construction
List Bullet Qualification support

Commissioning

2005


Example 4
One of the world's largest bio­pharmaceutical capital investments - Wyeth BioPharma Campus Dublin


Ireand

Client

Wyeth Medica Ireland

Location

Grange Castle Campus, Dublin / Ireland

Product

ENBREL® Pneumococcal Conjugate Vaccine

Type of plant

The world's largest biopharmaceutical campus. Multi product campus with 3 separate facilities for
List Bullet Drug development
List Bullet Drug substance
List Bullet Finished products

as well as QA/QC and infrastructure

Scope of work

List Bullet Consulting during Integrated Construction and Validation (ICV)
List Bullet Work on Acceleration program, introduction of shift work up to 24/7, de-bottlenecking
List Bullet Set-up of overall real time tracking system for all ICV activities
- Improved control of execution
- Risk reduction

Planning period

2003 / 2004


Example 5
Insulin plant


Frankfurt

Client

Aventis Pharma Deutschland GmbH

Location

Frankfurt (Main) / Germany

Type of plant

General planner for design and construction of the plant for the production of insulin glargine (trade name Lantus®)

Product

Recombinant insulin analogon with depot effect

Production process

Biotechnological fermentation

Scope of work

List Bullet General planner for design and construction, engineering „Lump sum“
List Bullet Basic and detail engineering, procurement (on behalf and on account), civil and construction, commissioning, qualification

Start-up

2002



Further references

Vaccines

Planning of a new plant for the biotechnological production of three vaccines for GlaxoSmith Kline Biologicals Kft. in Gödöllö (Hungary), 2003

Recombinant coagulation factors

Planning of a plant for the production of the pharmaceutical ingredient in high-cell-density perfusion cultures of BHK cells and purification of the glycoprotein for the Bayer AG in Wuppertal (Germany), know how and technology transfer from production and R&D into design basis, conceptual design for all disciplines, 2001




Website Finder

Page History

Back Print
Copyright Linde-KCA-Dresden GmbH 2006 Sitemap Contact Imprint Deutsch